Shukra Pharmaceuticals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast closeFY24Mar 2024FY23Mar 2023
₹23.00₹23.00₹26.21
₹71.52₹71.52₹150.47
₹92.53₹92.53₹349.94
−₹6.45−₹6.45₹18.85
−₹8.63−₹8.63−₹7.86
₹0.09₹0.09₹0.43
0.80.80.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SHUKRAPHAR₹71.92

Shukra Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSUNLOCMcap ₹58 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
Current
last close
Basic EPS26.2123.0023.00
Book Value per Share150.4771.5271.52
Revenue per Share349.9492.5392.53
Cash Flow per Share18.85-6.45-6.45
Free Cash Flow per Share-7.86-8.63-8.63
Dividends per Share0.430.090.09
Shares Outstanding (cr)0.20.80.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.